JPMorgan Chase & Co’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-24,345
Closed -$79K 6402
2022
Q4
$79K Buy
24,345
+4,260
+21% +$13.8K ﹤0.01% 4573
2022
Q3
$59K Buy
20,085
+14,264
+245% +$41.9K ﹤0.01% 4655
2022
Q2
$14K Sell
5,821
-21,575
-79% -$51.9K ﹤0.01% 5130
2022
Q1
$221K Hold
27,396
﹤0.01% 4395
2021
Q4
$364K Buy
27,396
+8,420
+44% +$112K ﹤0.01% 4231
2021
Q3
$828K Buy
18,976
+11,873
+167% +$518K ﹤0.01% 3714
2021
Q2
$297K Buy
7,103
+1,856
+35% +$77.6K ﹤0.01% 4291
2021
Q1
$254K Buy
5,247
+838
+19% +$40.6K ﹤0.01% 4366
2020
Q4
$433K Buy
4,409
+3,183
+260% +$313K ﹤0.01% 3826
2020
Q3
$84K Buy
1,226
+120
+11% +$8.22K ﹤0.01% 4127
2020
Q2
$117K Buy
1,106
+332
+43% +$35.1K ﹤0.01% 3895
2020
Q1
$69K Sell
774
-27
-3% -$2.41K ﹤0.01% 4047
2019
Q4
$91K Sell
801
-10,573
-93% -$1.2M ﹤0.01% 4062
2019
Q3
$703K Buy
11,374
+10,901
+2,305% +$674K ﹤0.01% 3222
2019
Q2
$36K Sell
473
-98
-17% -$7.46K ﹤0.01% 4383
2019
Q1
$77K Buy
571
+174
+44% +$23.5K ﹤0.01% 4086
2018
Q4
$32K Sell
397
-10,892
-96% -$878K ﹤0.01% 4406
2018
Q3
$1.19M Buy
11,289
+5,172
+85% +$543K ﹤0.01% 3073
2018
Q2
$612K Buy
6,117
+5,809
+1,886% +$581K ﹤0.01% 3364
2018
Q1
$39K Sell
308
-22
-7% -$2.79K ﹤0.01% 4231
2017
Q4
$55K Buy
+330
New +$55K ﹤0.01% 4102
2017
Q3
Sell
-87
Closed -$26K 4492
2017
Q2
$26K Buy
+87
New +$26K ﹤0.01% 3881
2016
Q4
Sell
-354
Closed -$23K 4584
2016
Q3
$23K Buy
354
+301
+568% +$19.6K ﹤0.01% 3733
2016
Q2
$4K Sell
53
-13,325
-100% -$1.01M ﹤0.01% 3991
2016
Q1
$1.52M Sell
13,378
-347
-3% -$39.4K ﹤0.01% 2492
2015
Q4
$2.1M Buy
+13,725
New +$2.1M ﹤0.01% 2353
2015
Q2
Sell
-6,374
Closed -$2.09M 3562
2015
Q1
$2.09M Sell
6,374
-212
-3% -$69.6K ﹤0.01% 2512
2014
Q4
$2.66M Buy
+6,586
New +$2.66M ﹤0.01% 2359